Nanoencapsulation of the omega-3 EPA:DHA 6:1 formulation enhances and sustains NO-mediated endothelium-dependent relaxations in coronary artery rings and NO formation in endothelial cells

Nanoencapsulation of the omega-3 EPA:DHA 6:1 formulation enhances and sustains NO-mediated endothelium-dependent relaxations in coronary artery rings and NO formation in endothelial cells

The eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) formulation with a ratio of 6:1 is a potent stimulator of the endothelial formation of nitric oxide (NO). The aim of the study was to investigate whether nanoencapsulation of EPA:DHA 6:1 followed by coating with gum increases its biologi...

Full description

Bibliographic Details
Main Authors: L. Remila, E. Belcastro, N. Guenday-Tuereli, S. Park, U. Houngue, T. Vandamme, E. Tuereli, P. Kerth, C. Auger, V. Schini-Kerth
Format: Article
Language:English
Published: Elsevier 2021-12-01
Series:Journal of Functional Foods
Subjects:
Omega-3
Nanoencapsulation
EPA:DHA 6:1
Endothelium
Nitric oxide
Online Access:http://www.sciencedirect.com/science/article/pii/S1756464621005004

Similar Items

Similar Items